E

Exscientia

484 employees

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Technology
Artificial Intelligence
Pharmaceutical
AI Drug Discovery
Tech Enabled Drug Development
Precision Medicine
Pharmaceuticals

Date founded

2012

Funding rounds raised

Total raised

$225M

from 18 investors over 18 rounds

E

Exscientia raised $1.5M on July 8, 2021

Investors: Bill & Melinda Gates Foundation

E

Exscientia raised $225M on April 20, 2021

Investors: Laurion Capital Management LP, SoftBank Investment Advisers, Novo Holdings, Casdin Capital, LLC, Marshall Wace and Farallon Capital Management

E

Exscientia raised $40M on March 4, 2021

Investors: Evotec, Novo Holdings and Bristol-Myers Squibb, UK

E

Exscientia raised $4.2M on December 10, 2020

Investors: Bill & Melinda Gates Foundation

E

Exscientia raised $60M on May 26, 2020

Investors: Evotec, Bristol-Myers Squibb, UK and Novo Holdings

E

Exscientia raised $26M on January 7, 2019

Investors: Celgene and Evotec

E

Exscientia raised $18M on September 28, 2017

Investors: Evotec

E

Exscientia raised undisclosed on June 30, 2016

Investors: Frontier IP Group plc

FAQ